SCHEMBL13587152

SCHEMBL13587152

COc1cc2nccc(Oc3ccc4nc(NC(=O)c5ccc(S(C)(=O)=O)s5)sc4c3)c2cc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 3/20 0.63
KDM4E B2RXH2 8/20 0.51
ALDH1A1 P00352 5/20 0.51
RAB9A P51151 5/20 0.51
NPSR1 Q6W5P4 4/20 0.51
NPC1 O15118 4/20 0.51
TP53 P04637 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 2/20 0.51
POLB P06746 1/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
AXL P30530 3/20 0.50
KDR P35968 6/20 0.49
RXFP1 Q9HBX9 3/20 0.48
PDGFRA P16234 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13587155 0.88 MET (0.67) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL13587167 0.87 MET (0.66) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL13587154 0.87 NPC1 (0.68) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL13587159 0.86 MET (0.64) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL4380458 0.85 MET (0.67) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL13587174 0.84 AXL (0.71) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL4375037 0.84 MET (0.64) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL4379209 0.84 MET (0.70) METKDM4EALDH1A1RAB9ANPSR1
SCHEMBL4368604 0.83 MET (0.77) METRAB9ANPC1TP53MEN1
SCHEMBL4370355 0.82 MET (0.73) METKDM4EALDH1A1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7626030-B2 Compounds and methods of use AMGEN INC. (US) 2009-12-01 US disclosed
US-7626030-B2 Compounds and methods of use AMGEN INC. (US) 2009-12-01 US disclosed